Sarepta Therapeutics Inc. (SRPT)
Sarepta Therapeutics Max Pain By Strike
SRPT trades at $21.82, 14.8% above the near-term max pain of $19 expiring Aug 15, 2025 (-1 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($2.5-$22.5), reflecting growing call interest at higher strikes. Key magnetic zone at 15 where 4 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Sarepta Therapeutics Max Pain By Expiry
Max pain for SRPT shows an upward trend from 2.5 to 22.5, suggesting bullish positioning in longer-dated options. The 129% spread signals divergent expectations across timeframes. Most levels below 21.82 may cap rallies. Strong magnetic level at 15 (4 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 15, 2025 | 19 | -2.82 (-12.94%) |
| Aug 22, 2025 | 16.5 | -5.32 (-24.40%) |
| Aug 29, 2025 | 16 | -5.82 (-26.69%) |
| Sep 5, 2025 | 16 | -5.82 (-26.69%) |
| Sep 12, 2025 | 15 | -6.82 (-31.27%) |
| Sep 19, 2025 | 17.5 | -4.32 (-19.82%) |
| Sep 26, 2025 | 15 | -6.82 (-31.27%) |
| Oct 17, 2025 | 2.5 | -19.32 (-88.55%) |
| Nov 21, 2025 | 20 | -1.82 (-8.36%) |
| Jan 16, 2026 | 22.5 | 0.68 (3.09%) |
| Feb 20, 2026 | 15 | -6.82 (-31.27%) |
| Jun 18, 2026 | 17.5 | -4.32 (-19.82%) |
| Jan 15, 2027 | 15 | -6.82 (-31.27%) |
| Dec 17, 2027 | 10 | -11.82 (-54.18%) |